Company / Capital Expenditures
Core Scientific, Inc./tx Capital Expenditures History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$729.0M
FY2025
5-year range
$0 / $729.0M
FY2021-FY2025
Trend
+667.7%
vs FY2024
Sector context
#14 of 296
Financials
What the data says
Capital Expenditures changed +668% YoY in FY2025, a notable deviation from the 3-year average annual change of +353%.
Based on SEC 10-K filings.
$729M in FY2025 with a 3-year CAGR of +23.8%. Top quartile in the Financials sector.
Improved from $16M to $729M over the past 2 years.
Financials sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +23.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 5% in FinancialsTop 5% of 296This company $729.0M Sector average $203.0M
▼
+259.1% above sector average
Key checks
Key Insights
- 3-year CAGR of +23.8%, indicating consistent growth.
- In FY2025, capital expenditures increased 667.7% year-over-year.
- Ranks #14 out of 296 companies in the Financials sector.
- Lowest capital expenditures in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -1.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $729.0M | +667.7% |
| FY2024 | $95.0M | +487.6% |
| FY2023 | $16.2M | -95.8% |
| FY2022 | $384.0M | - |
| FY2021 | $0 | - |
| FY2020 | $0 | - |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026